Expression of apoptosis on rat liver by hepatic vagus hyperactivity after ventromedial hypothalamic lesioning

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 280, Issue 5 43-5, 2001, Pages

  Kiba, Takayoshi ^a   Saito, Satoru ^a   Numata, Kazushi ^a   Kon, Yasuhiro ^b   Mizutani, Tetsuya ^c   Sekihara, Hisahiko ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Fas; Fas ligand; Vagus nerve; Ventromedial hypothalamus

Indexed keywords

ATROPINE; CASPASE 3; FAS ANTIGEN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INJURY; CELL MEMBRANE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; CYTOPLASM; ELECTRON MICROSCOPY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; IMMUNOHISTOCHEMISTRY; KUPFFER CELL; LIVER CELL; LIVER SINUSOID; NERVE CONDUCTION; NICK END LABELING; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPECTROFLUOROMETRY; VAGOTOMY; VAGUS NERVE; WESTERN BLOTTING;

EID: 0035031845     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.2001.280.5.g958     Document Type: Article

References (70)

1. Adachi M, Suematsu S, Kondo T, Ogasawara J, Tanaka T, Yoshida N, and Nagata S. Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat Genet 11: 294-300, 1995.
2. Akiyama T, Tachibana I, Shirohara H, Watanabe N, and Otsuki M. High-fat hypercaloric diet induces obesity, glucose intolerance and hyperlipidemia in normal adult male Wistar rat. Diabetes Res Clin Pract 31: 27-35, 1996.
3. Antonica A, Magni F, Mearini L, and Paolocci N. Vagal control of lymphocyte release from rat thymus. J Auton Nerv Syst 48: 187-197, 1994.
4. Arakawa H, Kodama H, Matsuoka N, and Yamaguchi I. Stress increases plasma enzyme activity in rats: differential effects of adrenergic and cholinergic blockades. J Pharmacol Exp Ther 280: 1296-1303, 1997.
5. Armstrong RC, Aja T, Xiang J, Gaur S, Krebs JF, Hoang K, Bai X, Korsmeyer SJ, Karanewsky DS, Fritz LC, and Tomaselli KJ. Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors. J Biol Chem 271: 16850-16855, 1996.
6. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, and Duke RC. A role for CD95 ligand in preventing graft rejection. Nature 377: 630-632, 1995.
7. Blanco-Rodriguez J and Martinez-Garcia C. Spontaneous germ cell death in the testis of the adult rat takes the form of apoptosis: re-evaluation of cell types that exhibit the ability to die during spermatogenesis. Cell Prolif 29: 13-31, 1996.
8. Blin N and Stafford DW. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res 3: 2303-2308, 1976.
9. Boldin MP, Goncharov TM, Goltsev YV, and Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85: 803-815, 1996.
10. Bonfoco E, Stuart PM, Brunner T, Lin T, Griffith TS, Gao Y, Nakajima H, Henkart PA, Ferguson TA, and Green DR. Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells. Immunity 9: 711-720, 1998.
11. Bray GA and York DA. Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol Rev 59: 719-809, 1979.
12. Bursch W, Lauer B, Timmermann-Trosiener I, Barthel G, Schuppler J, and Schulte-Hermann R. Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis 5: 453-458, 1984.
13. Bursch W, Oberhammer F, and Schulte-Hermann R. Cell death by apoptosis and its protective role against disease. Trends Pharmacol Sci 13: 245-251, 1992.
14. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, and Mountz JD. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263: 1759-1762, 1994.
15. Deaciuc IV, D'Souza NB, and Spitzer JJ. Tumor necrosis factor-α cell-surface receptors of liver parenchymal and non-parenchymal cells during acute and chronic alcohol administration to rats. Alcohol Clin Exp Res 19: 332-338, 1995.
16. De Groot J. The rat hypothalamus in stereotaxic coordinates. J Comp Neurol 113: 389-400, 1959.
17. Dhein J, Daniel PT, Trauth BC, Oehm A, Moller P, and Krammer PH. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J Immunol 149: 3166-3173, 1992.
18. Enari M, Talanian RV, Wong WW, and Nagata S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380: 723-726, 1996.
19. Feldmann G. Liver apoptosis. J Hepatol 26, Suppl 2: 1-11, 1997.
20. French LE, Hahne M, Viard I, Radlgruber G, Zanone R, Becker K, Muller C, and Tschopp J. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J Cell Biol 133: 335-343, 1996.
21. French LE, Wilson A, Hahne M, Viard I, Tschopp J, and MacDonald HR. Fas ligand expression is restricted to nonlymphoid thymic components in situ. J Immunol 159: 2196-2202, 1997.
22. Frucht H, Jensen RT, Dexter D, Yang WL, and Xiao Y. Human colon cancer cell proliferation mediated by the M3 muscarinic cholinergic receptor. Clin Cancer Res 5: 2532-2539, 1999.
23. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, Krammer PH, and Runkel L. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 182: 1223-1230, 1995.
24. Gavrieli Y, Sherman Y, and Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501, 1992.
25. Griffith TS, Brunner T, Fletcher SM, Green DR, and Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270: 1189-1192, 1995.
26. Griffith TS, Yu X, Herndon JM, Green DR, and Ferguson TA. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 5: 7-16, 1996.
27. Hakuno N, Koji T, Yano T, Kobayashi N, Tsutsumi O, Taketani Y, and Nakane PK. Fas/APO-1/CD95 system as a mediator of granulosa cell apoptosis in ovarian follicle atresia. Endocrinology 137: 1938-1948, 1996.
28. Henkart PA. ICE family proteases: mediators of all apoptotic cell death? Immunity 4: 195-201, 1996.
29. Hiramatsu N, Hayashi N, Katayama K, Mochizuki K, Kawanishi Y, Kasahara A, Fusamoto H, and Kamada T. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 19: 1354-1359, 1994.
30. Hockenbery D. Defining apoptosis. Am J Pathol 146: 16-19, 1995.
31. Kato H and Shimazu T. Effect of autonomic denervation on DNA synthesis during liver regeneration after partial hepatectomy. Eur J Biochem 134: 473-478, 1983.
32. Kiba T, Tanaka K, Endo O, and Inoue S. Role of vagus nerve in increased DNA synthesis after hypothalamic ventromedial lesions in rat liver. Am J Physiol Gastrointest Liver Physiol 262: G483-G487, 1992.
33. Kiba T, Tanaka K, Endo O, and Inoue S. Ventromedial hypothalamic lesions increase gastrointestinal DNA synthesis through vagus nerve in rats. Gastroenterology 104: 475-484, 1993.
34. Kiba T, Tanaka K, Inoue S, Endo O, and Takamura Y. Comparison of DNA contents of visceral organs in rats with ventromedial hypothalamic lesions and fed a high fat diet. Neurosci Lett 126: 127-130, 1991.
35. Kiba T, Tanaka K, Numata K, Hoshino M, and Inoue S. Facilitation of liver regeneration after partial hepatectomy by ventromedial hypothalamic lesions in rats. Pflügers Arch 428: 26-29, 1994.
36. Kiba T, Tanaka K, Numata K, Hoshino M, Misugi K, and Inoue S. Ventromedial hypothalamic lesion-induced vagal hyperactivity stimulates rat pancreatic cell proliferation. Gastroenterology 110: 885-893, 1996.
37. Kiba T, Tanaka K, Numata K, Saito S, and Sekihara H. Hepatocyte proliferation in rats after ventromedial hypothalamic lesions: immunoreactivity patterns of proliferating cell nuclear antigen (PCNA). J Gastroenterol 33: 523-528, 1998.
38. Kimura K, Wakatsuki T, and Yamamoto M. A variant mRNA species encoding a truncated form of Fas antigen in the rat liver. Biochem Biophys Res Commun 198: 666-674, 1994.
39. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
40. Lamers WH, Hilberts A, Furt E, Smith J, Jonges GN, van Noorden CJ, Janzen JW, Charles R, and Moorman AF. Hepatic enzymic zonation: a reevaluation of the concept of the liver acinus. Hepatology 10: 72-76, 1989.
41. LeSage G, Alvaro D, Benedetti A, Glaser S, Marucci L, Baiocchi L, Eisel W, Caligiuri A, Phinizy JL, Rodgers R, Francis H, and Alpini G. Cholinergic system modulates growth, apoptosis, and secretion of cholangiocytes from bile duct-ligated rats. Gastroenterology 117: 191-199, 1999.
42. Longthorne VL and Williams GT. Caspase activity is required for commitment to Fas-mediated apoptosis. EMBO J 16: 3805-3812, 1997.
43. Lu L, Qian S, Hershberger PA, Rudert WA, Lynch DH, and Thomson AW. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J Immunol 158: 5676-5684, 1997.
44. Lynch JP, Wojnar MM, and Lang CH. Ventromedial hypothalamic lesions impair glucoregulation in response to endotoxin. Am J Physiol Regulatory Integrative Comp Physiol 272: R1525-R1531, 1997.
45. Milich DR, Chen MK, Hughes JL, and Jones JE. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. J Immunol 160: 2013-2021, 1998.
46. Mita E, Hayashi N, Iio S, Takehara T, Hijioka T, Kasahara A, Fusamoto H, and Kamada T. Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem Biophys Res Commun 204: 468-474, 1994.
47. Mochizuki K, Hayashi N, Hiramatsu N, Katayama K, Kawanishi Y, Kasahara A, Fusamoto H, and Kamada T. Fas antigen expression in liver tissues of patients with chronic hepatitis B. J Hepatol 24: 1-7, 1996.
48. Mori C, Nakamura N, Dix DJ, Fujioka M, Nakagawa S, Shiota K, and Eddy EM. Morphological analysis of germ cell apoptosis during postnatal testis development in normal and Hsp 70-2 knockout mice. Dev Dyn 208: 125-136, 1997.
49. Mulholland MW, Bonsack M, and Delaney JP. Proliferation of gastric endocrine cells after vagotomy in the rat. Endocrinology 117: 1578-1584, 1985.
50. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, and Dixit VM. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817-827, 1996.
51. Nagata S. Apoptosis by death factor. Cell 88: 355-365, 1997.
52. Nagata S and Golstein P. The Fas death factor. Science 267: 1449-1456, 1995.
53. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, and Nagata S. Lethal effect of the anti-Fas antibody in mice. Nature 364: 806-809, 1993.
54. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6, 1994.
55. Roy N, Mahadevan MS, McLean M, Shutler G, Yaraghi Z, Farahani R, Baird S, Besner-Johnston A, Lefebvre C, and Kang X. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80: 167-178, 1995.
56. Sambrook J, Fritsch EF, and Maniatis T. Molecular Cloning: A Laboratory Manual (2nd ed.). New York: Cold Spring Harbor Laboratory, 1989.
57. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, and Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85, 1985.
58. Staley K, Blaschke AJ, and Chun J. Apoptotic DNA fragmentation is detected by a semi-quantitative ligation-mediated PCR of blunt DNA ends. Cell Death Differ 4: 66-75, 1996.
59. Suda T, Takahashi T, Golstein P, and Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75: 1169-1178, 1993.
60. Suss G and Shortman K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J Exp Med 183: 1789-1796, 1996.
61. Taniuchi M, Clark HB, and Johnson EM Jr. Induction of nerve growth factor receptor in Schwann cells after axotomy. Proc Natl Acad Sci USA 83: 4094-4098, 1986.
62. Terada T and Nakanuma Y. Detection of apoptosis and expression of apoptosis-related proteins during human intrahepatic bile duct development. Am J Pathol 146: 67-74, 1995.
63. Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W, Debatin KM, and Krammer PH. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301-305, 1989.
64. Vaux DL, Cory S, and Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440-442, 1988.
65. Vignaux F, Vivier E, Malissen B, Depraetere V, Nagata S, and Golstein P. TCR/CD3 coupling to Fas-based cytotoxicity. J Exp Med 181: 781-786, 1995.
66. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, and Nagata S. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 148: 1274-1279, 1992.
67. Willingham MC. Cytochemical methods for the detection of apoptosis. J Histochem Cytochem 47: 1101-1110, 1999.
68. Wyllie AH, Kerr JF, and Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 68: 251-306, 1980.
69. Yonehara S, Ishii A, and Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169: 1747-1756, 1989.
70. Yoshimatsu H, Niijima A, Oomura Y, and Katafuchi T. Lateral and ventromedial hypothalamic influences on hepatic autonomic nerve activity in the rat. Brain Res Bull 21: 239-244, 1988.